Developer docs
API playgroundTry for free, no card

Search company profiles

Vomaris Innovations

Full company profile

uuid0003cjf

Namestring
Vomaris Innovations
Legal namestring
Vomaris Innovations, Inc.
Websiteurl
vomaris.com
Company typeenum
Private
Founded yearint
2004
Descriptiontext

Vomaris Innovations, Inc. is a Tempe, Arizona-based private medical device company founded in 2004 that develops and commercializes bioelectric wound care products powered by its proprietary V.Dox Technology platform. The core technology uses a patented matrix of moisture-activated microcell batteries composed of elemental silver and elemental zinc embedded in a substrate; contact with a conductive medium such as saline or wound hydrogel triggers a REDOX reaction that generates a wireless microcurrent field mimicking the skin's natural transepithelial potential and current of injury, intended to support cell migration, re-epithelialization, and antimicrobial activity against biofilm-forming and antibiotic-resistant bacteria. The company monetizes through four distinct revenue streams: prescription-only Procellera Antimicrobial Wound Dressings sold direct to healthcare professionals; JumpStart-branded antibacterial wound dressings distributed through an exclusive global partnership with Arthrex across orthopedic, sports medicine, spine, and cardiothoracic surgery channels; over-the-counter PowerHeal Bioelectric Bandages sold direct-to-consumer via powerhealbandage.com and Amazon; and licensing royalties plus dedicated military distribution through Lovell Gov for combat and tactical applications. The company is privately held, operates as a portfolio entity under Arthrex, Inc., and is led by President and CEO Michael P. Nagel, who has held the role since 2012.

Short descriptiontext

Vomaris Innovations is a private medical device company that develops and commercializes bioelectric wound care products powered by its proprietary V.Dox microcurrent technology, serving prescription, orthopedic, military, and over-the-counter consumer segments through direct sales, an exclusive Arthrex partnership, and e-commerce channels.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersTempe, United States
HQ citystring
Tempe
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
bioelectric wound care, antimicrobial wound dressings, advanced wound care devices, post-surgical wound management, biofilm infection treatment
Industry4 codes
PRIMARYHLAHALAC
Antimicrobial Wound Care (Silver/Iodine/PHMB Dressings, Wound Irrigation)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Wound Care, Ostomy & Continence Products
SECONDARYHLAHALAA
Advanced Wound Dressings (Foam, Hydrocolloid, Alginate, Hydrogel, Film)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Wound Care, Ostomy & Continence Products
SECONDARYCRADAMAB
First Aid & Wound Care (Bandages, Dressings, Antiseptics, Burn Care)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYHLAKAGAK
Wound Care & Diabetic Foot Infection
NAICS code3 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Surgical and Medical Instrument Manufacturing339112
  • Surgical Appliance and Supplies Manufacturing339113
SIC code3 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Advanced Wound Care Devices
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Prescription Wound Care Products
TypeOne Time License
Description

Procellera Antimicrobial Wound Dressings sold via prescription to healthcare professionals and hospitals for management of partial and full-thickness wounds across multiple medical and surgical specialties.

vomaris.com
2OTC Consumer Products
TypeHardware Sales
Description

PowerHeal Antibacterial Bioelectric Bandages sold directly to consumers over-the-counter for superficial wounds via powerhealbandage.com and Amazon.

vomaris.com
3Orthopedic/Sports Medicine Products
TypeOthers
Description

JumpStart Antibacterial Wound Dressings distributed exclusively through Arthrex for orthopedic surgery, sports medicine, spine, and cardiothoracic surgery applications.

vomaris.com
4Licensing Royalties
TypeLicensing Royalties
Description

Licensing arrangement with Arthrex for exclusive global distribution rights in orthopedics and sports medicine markets.

vomaris.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations
Pricing details3 tiers
1Prescription Products - Procellera
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Quote-based pricing through healthcare professional inquiry

vomaris.com
2OTC Consumer Products - PowerHeal
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Available for purchase on powerhealbandage.com and Amazon marketplace

vomaris.com
3Orthopedic Products - JumpStart via Arthrex
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Available through Arthrex orthopedic distribution network

vomaris.com
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1V.Dox Technology
Description

Patented bioelectric technology platform using moisture-activated microcell batteries to generate microcurrents for wound healing and antimicrobial protection.

vomaris.com
+2 more records
Core offering1 text field

Vomaris Innovations develops and commercializes bioelectric wound care products powered by its proprietary V.Dox Technology. The platform uses moisture-activated microcell batteries (elemental silver and zinc) that generate wireless microcurrents via a REDOX reaction to mimic the skin's natural transepithelial potential, providing antimicrobial protection and supporting wound healing. The company sells prescription Procellera dressings to healthcare providers, OTC PowerHeal bandages to consumers, and JumpStart dressings to orthopedic surgeons through Arthrex.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 45.5% improvement in healing time vs standard of care (19.8 days vs 36.3 days)
+6 more records
Product overview1 text field

Vomaris Innovations offers a portfolio of bioelectric wound care products powered by V.Dox™ Technology—a proprietary platform using moisture-activated microcell batteries (elemental silver and zinc) that generate microcurrents mimicking the skin's natural electrical energy. The core products include Procellera® Antimicrobial Wound Dressings (prescription) and PowerHeal™ Bioelectric Bandages (OTC), with specialized versions for orthopedics (JumpStart® via Arthrex), post-surgical care (Procellera FlexEFit™, Procellera Helix Post-Op®), and athletic performance (PERFORM compression garments). The technology platform has demonstrated efficacy against biofilm-forming and antibiotic-resistant bacteria without the use of antibiotics.

Product and service6 records
1Procellera Antimicrobial Wound Dressings
CategoryPrescription Wound Care / Rx Dressings
Description

Prescription-only bioelectric wound dressing powered by V.Dox Technology, using moisture-activated microcell batteries (silver and zinc) to generate microcurrents that mimic the skin's natural electrical energy. Sold to healthcare professionals and hospitals for management of partial and full-thickness wounds, including chronic wounds, surgical site infections, and burns.

2PowerHeal Bioelectric Bandages
CategoryConsumer OTC Wound Care
Description

Over-the-counter bioelectric bandage for superficial wounds. World's first and only OTC bioelectric bandage, powered by V.Dox Technology. Available at powerhealbandage.com and Amazon for individual consumers.

3JumpStart Antibacterial Wound Dressings
CategoryOrthopedic Wound Care
Description

Branded version of Procellera distributed exclusively by Arthrex for orthopedic surgery, sports medicine, spine, and cardiothoracic surgery applications. Provides post-surgical infection prevention and accelerated wound healing.

4Procellera FlexEFit Antibacterial Wound Dressing
CategoryPost-Surgical Wound Care
Description

Post-surgical wound dressing with 'Link & Build' design that can be configured during application to seamlessly cover incisions of virtually any length or curvature with one product configuration. Used by orthopedic surgeons for post-surgical wound management.

5Procellera Helix Post-Op
CategoryPost-Surgical Wound Care
Description

Post-operative surgical dressing applied directly over sutures, staples, steri-strips and liquid skin adhesives. Features stress-shielding design to reduce suture site stress and improve healing outcomes.

6OrthoElite
CategoryOrthopedic Wound Care
Description

Product line designed specifically to contour and move with various joints for orthopedic applications. Distributed through Arthrex partnership.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-03-10
Description

Collaborative research on biofilm in burn wounds. Blinded sample analysis conducted at Indiana Center for Regenerative Medicine and Engineering under Dr. Sashwati Roy.

2Brooke Army Medical Center / U.S. Army Institute of Surgical Research Burn Center
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-03-10
Description

Randomized controlled clinical trial on bioelectric technology effectiveness against burn wound biofilm infection. Led by Dr. Rodney Chan.

vomaris.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2017-12-05
Description

Leading research on anti-biofilm efficacy, mechanism of action, and wound healing outcomes. Dr. Chandan Sen leads Comprehensive Wound Center research.

Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2015-09-18
Description

Partnership to support CAF Elite Paratriathlon Team with Procellera wound dressings for training and competition injuries. Renewed partnership for second year of support.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2015-01-30
Description

Exclusive global commercial and development partnership for Procellera technology in orthopedics and sports medicine markets. Arthrex distributes products under JumpStart brand name. Arthrex is a global medical device company operating in over 90 countries.

6U.S. Army Medical Materiel Command (USAMMA)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2013-10-30
Description

$1 million research grant to fund clinical study evaluating Procellera versus current Army methods on acute wound healing in U.S. Army Rangers at Fort Benning, Georgia.

vomaris.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2013-02-19
Description

Research collaboration including data management, regulatory support, site monitoring, and quantitative analysis on biomarkers and bacteriology. Partner on Combat Wound Initiative with Walter Reed.

8Walter Reed National Military Medical Center
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2013-02-19
Description

Combat Wound Initiative study assessing clinical efficacy of bioelectric dressing on chronic soft tissue wound healing rate over 12-week treatment period.

vomaris.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global medical device incumbent with a major Advanced Wound Management franchise (Allevyn, PICO single-use NPWT, ACTICOAT). Competes directly with Vomaris in antimicrobial and advanced wound dressings sold to hospitals and clinicians, and dwarfs Vomaris in commercial reach.

TypeBroad incumbent
Description

Owns the V.A.C. negative pressure wound therapy franchise and a broad advanced wound care portfolio, making it one of the largest scaled players in the same hospital wound care channel where Vomaris sells Procellera and JumpStart.

TypeBroad incumbent
Description

Pure-play advanced wound care and ostomy company with brands such as Aquacel and FoamLite. Directly comparable product portfolio in antimicrobial and moisture-management dressings, sold through the same hospital formularies and home care channels Vomaris targets.

TypeBroad incumbent
Description

Swedish wound care specialist behind the Mepilex, Mepitel and Avance NPWT lines, with deep operating-room and burn care presence. Competes directly with Vomaris in post-surgical and chronic wound dressings globally.

TypeBroad incumbent
Description

Danish medical device leader in wound care (Biatain, Conveen) and ostomy. Shares the same chronic wound care customer base and pursues adjacent antimicrobial and bio-active dressing technologies that overlap with Vomaris's positioning.

TypeDirect peer
Description

US-listed regenerative medicine company commercializing skin substitutes and active wound care biologics (Apligraf, Dermagraft, PuraPly). Closest publicly traded analog to Vomaris in selling clinically differentiated, premium-priced advanced wound therapies to the same wound care clinicians.

TypeDirect peer
Description

Regenerative wound care and surgical recovery company selling dehydrated amniotic tissue allografts (EpiFix, AmnioFix). Competes for the same surgical wound care and chronic wound care prescribers and shares Vomaris's premium-pricing, evidence-led go-to-market.

TypeDirect peer
Description

Specialty medical device company with a dedicated Wound Care and Surgical Reconstruction franchise (Integra dermal regeneration templates, PriMatrix, AmnioExcel). Sells into the same burn, reconstructive and surgical wound care channels Vomaris targets.

TypeBroad incumbent
Description

Global medical device and IV solutions manufacturer with a meaningful wound care portfolio (Askina, Prontosan). Competes with Vomaris in hospital-acquired wound care and shares the European/international channels relevant to global expansion.

TypeOthers
Description

Major medical products distributor and manufacturer with wound care products (e.g., Kendall AMD antimicrobial dressings, Cardinal Health-brand dressings). Comparable primarily as a distribution and dressing competitor in US hospitals and home health.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Vomaris Innovations

Advanced Wound Care Devicesvomaris.com

Vomaris Innovations is a private medical device company that develops and commercializes bioelectric wound care products powered by its proprietary V.Dox microcurrent technology, serving prescription, orthopedic, military, and over-the-counter consumer segments through direct sales, an exclusive Arthrex partnership, and e-commerce channels.

What Vomaris Innovations does

Vomaris Innovations, Inc. is a Tempe, Arizona-based private medical device company founded in 2004 that develops and commercializes bioelectric wound care products powered by its proprietary V.Dox Technology platform. The core technology uses a patented matrix of moisture-activated microcell batteries composed of elemental silver and elemental zinc embedded in a substrate; contact with a conductive medium such as saline or wound hydrogel triggers a REDOX reaction that generates a wireless microcurrent field mimicking the skin's natural transepithelial potential and current of injury, intended to support cell migration, re-epithelialization, and antimicrobial activity against biofilm-forming and antibiotic-resistant bacteria. The company monetizes through four distinct revenue streams: prescription-only Procellera Antimicrobial Wound Dressings sold direct to healthcare professionals; JumpStart-branded antibacterial wound dressings distributed through an exclusive global partnership with Arthrex across orthopedic, sports medicine, spine, and cardiothoracic surgery channels; over-the-counter PowerHeal Bioelectric Bandages sold direct-to-consumer via powerhealbandage.com and Amazon; and licensing royalties plus dedicated military distribution through Lovell Gov for combat and tactical applications. The company is privately held, operates as a portfolio entity under Arthrex, Inc., and is led by President and CEO Michael P. Nagel, who has held the role since 2012.

Vomaris Innovations firmographics

Firmographics
Name
Vomaris Innovations
Legal name
Vomaris Innovations, Inc.
Website
https://vomaris.com
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
1–10 employees
Short description
Vomaris Innovations is a private medical device company that develops and commercializes bioelectric wound care products powered by its proprietary V.Dox microcurrent technology, serving prescription, orthopedic, military, and over-the-counter consumer segments through direct sales, an exclusive Arthrex partnership, and e-commerce channels.
Ownership category
akta.pro rank

Vomaris Innovations industry classification

Industry
Product category
Advanced Wound Care Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro industry
PRIMARYHLAHALAC
Antimicrobial Wound Care (Silver/Iodine/PHMB Dressings, Wound Irrigation)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Wound Care, Ostomy & Continence Products
SECONDARYHLAHALAA
Advanced Wound Dressings (Foam, Hydrocolloid, Alginate, Hydrogel, Film)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Wound Care, Ostomy & Continence Products
SECONDARYCRADAMAB
First Aid & Wound Care (Bandages, Dressings, Antiseptics, Burn Care)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYHLAKAGAK
Wound Care & Diabetic Foot Infection

Keywords

  • Bioelectric wound care
  • Antimicrobial wound dressings
  • Advanced wound care devices
  • Post-surgical wound management
  • Biofilm infection treatment

Where Vomaris Innovations is headquartered

Location

Headquarters

HQ city
Tempe
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Vomaris Innovations business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. Prescription Wound Care Products: Procellera Antimicrobial Wound Dressings sold via prescription to healthcare professionals and hospitals for management of partial and full-thickness wounds across multiple medical and surgical specialties.
  2. OTC Consumer Products: PowerHeal Antibacterial Bioelectric Bandages sold directly to consumers over-the-counter for superficial wounds via powerhealbandage.com and Amazon.
  3. Orthopedic/Sports Medicine Products: JumpStart Antibacterial Wound Dressings distributed exclusively through Arthrex for orthopedic surgery, sports medicine, spine, and cardiothoracic surgery applications.
  4. Licensing Royalties: Licensing arrangement with Arthrex for exclusive global distribution rights in orthopedics and sports medicine markets.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goPrescription Products - Procellera
Unit PricingPay-as-you-goOTC Consumer Products - PowerHeal
One time/ perpetual licensePay-as-you-goOrthopedic Products - JumpStart via Arthrex

Go-to-market motion3 records

Distribution channels5 records

Marketing channels8 records

Vomaris Innovations product offering

Product offering

Core offering

Vomaris Innovations develops and commercializes bioelectric wound care products powered by its proprietary V.Dox Technology. The platform uses moisture-activated microcell batteries (elemental silver and zinc) that generate wireless microcurrents via a REDOX reaction to mimic the skin's natural transepithelial potential, providing antimicrobial protection and supporting wound healing. The company sells prescription Procellera dressings to healthcare providers, OTC PowerHeal bandages to consumers, and JumpStart dressings to orthopedic surgeons through Arthrex.

Product overview

Vomaris Innovations offers a portfolio of bioelectric wound care products powered by V.Dox™ Technology—a proprietary platform using moisture-activated microcell batteries (elemental silver and zinc) that generate microcurrents mimicking the skin's natural electrical energy. The core products include Procellera® Antimicrobial Wound Dressings (prescription) and PowerHeal™ Bioelectric Bandages (OTC), with specialized versions for orthopedics (JumpStart® via Arthrex), post-surgical care (Procellera FlexEFit™, Procellera Helix Post-Op®), and athletic performance (PERFORM compression garments). The technology platform has demonstrated efficacy against biofilm-forming and antibiotic-resistant bacteria without the use of antibiotics.

Differentiator

Problem solved

Functional benefit

Brands

  • V.Dox Technology: Patented bioelectric technology platform using moisture-activated microcell batteries to generate microcurrents for wound healing and antimicrobial protection.
  • Procellera FlexEFit
  • JumpStart

Products and services

  • Procellera Antimicrobial Wound Dressings Prescription-only bioelectric wound dressing powered by V.Dox Technology, using moisture-activated microcell batteries (silver and zinc) to generate microcurrents that mimic the skin's natural electrical energy. Sold to healthcare professionals and hospitals for management of partial and full-thickness wounds, including chronic wounds, surgical site infections, and burns.
  • PowerHeal Bioelectric Bandages Over-the-counter bioelectric bandage for superficial wounds. World's first and only OTC bioelectric bandage, powered by V.Dox Technology. Available at powerhealbandage.com and Amazon for individual consumers.
  • JumpStart Antibacterial Wound Dressings Branded version of Procellera distributed exclusively by Arthrex for orthopedic surgery, sports medicine, spine, and cardiothoracic surgery applications. Provides post-surgical infection prevention and accelerated wound healing.
  • Procellera FlexEFit Antibacterial Wound Dressing Post-surgical wound dressing with 'Link & Build' design that can be configured during application to seamlessly cover incisions of virtually any length or curvature with one product configuration. Used by orthopedic surgeons for post-surgical wound management.
  • Procellera Helix Post-Op Post-operative surgical dressing applied directly over sutures, staples, steri-strips and liquid skin adhesives. Features stress-shielding design to reduce suture site stress and improve healing outcomes.
  • OrthoElite Product line designed specifically to contour and move with various joints for orthopedic applications. Distributed through Arthrex partnership.

Quantifiable outcome

  • 45.5% improvement in healing time vs standard of care (19.8 days vs 36.3 days)
  • +6 more outcomes

Companies that use Vomaris Innovations

Customer profile

Named customers7 records

Segments7 records

Ideal customer profiles4 records

Vomaris Innovations technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Vomaris Innovations partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and minor.

  • Indiana University School of MedicinecoreStrategic or Co-development Partner · 10 March 2023Collaborative research on biofilm in burn wounds. Blinded sample analysis conducted at Indiana Center for Regenerative Medicine and Engineering under Dr. Sashwati Roy.
  • Brooke Army Medical Center / U.S. Army Institute of Surgical Research Burn CentercoreStrategic or Co-development Partner · 10 March 2023Randomized controlled clinical trial on bioelectric technology effectiveness against burn wound biofilm infection. Led by Dr. Rodney Chan.
  • The Ohio State University Wexner Medical CentercoreStrategic or Co-development Partner · 5 December 2017Leading research on anti-biofilm efficacy, mechanism of action, and wound healing outcomes. Dr. Chandan Sen leads Comprehensive Wound Center research.
  • Challenged Athletes Foundation (CAF)minorGTM or Marketing Partner · 18 September 2015Partnership to support CAF Elite Paratriathlon Team with Procellera wound dressings for training and competition injuries. Renewed partnership for second year of support.
  • Arthrex, Inc.coreChannel Partner/ Reseller/ Distributor · 30 January 2015Exclusive global commercial and development partnership for Procellera technology in orthopedics and sports medicine markets. Arthrex distributes products under JumpStart brand name. Arthrex is a global medical device company operating in over 90 countries.
  • U.S. Army Medical Materiel Command (USAMMA)coreStrategic or Co-development Partner · 30 October 2013$1 million research grant to fund clinical study evaluating Procellera versus current Army methods on acute wound healing in U.S. Army Rangers at Fort Benning, Georgia.
  • Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF)coreStrategic or Co-development Partner · 19 February 2013Research collaboration including data management, regulatory support, site monitoring, and quantitative analysis on biomarkers and bacteriology. Partner on Combat Wound Initiative with Walter Reed.
  • Walter Reed National Military Medical CentercoreStrategic or Co-development Partner · 19 February 2013Combat Wound Initiative study assessing clinical efficacy of bioelectric dressing on chronic soft tissue wound healing rate over 12-week treatment period.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Vomaris Innovations competitors and assessment

Company assessment

Broad incumbents

  • Smith+Nephew: Global medical device incumbent with a major Advanced Wound Management franchise (Allevyn, PICO single-use NPWT, ACTICOAT). Competes directly with Vomaris in antimicrobial and advanced wound dressings sold to hospitals and clinicians, and dwarfs Vomaris in commercial reach.
  • 3M Health Care (Solventum): Owns the V.A.C. negative pressure wound therapy franchise and a broad advanced wound care portfolio, making it one of the largest scaled players in the same hospital wound care channel where Vomaris sells Procellera and JumpStart.
  • Convatec: Pure-play advanced wound care and ostomy company with brands such as Aquacel and FoamLite. Directly comparable product portfolio in antimicrobial and moisture-management dressings, sold through the same hospital formularies and home care channels Vomaris targets.
  • Mölnlycke Health Care: Swedish wound care specialist behind the Mepilex, Mepitel and Avance NPWT lines, with deep operating-room and burn care presence. Competes directly with Vomaris in post-surgical and chronic wound dressings globally.
  • Coloplast: Danish medical device leader in wound care (Biatain, Conveen) and ostomy. Shares the same chronic wound care customer base and pursues adjacent antimicrobial and bio-active dressing technologies that overlap with Vomaris's positioning.
  • B. Braun: Global medical device and IV solutions manufacturer with a meaningful wound care portfolio (Askina, Prontosan). Competes with Vomaris in hospital-acquired wound care and shares the European/international channels relevant to global expansion.

Direct peers

  • Organogenesis: US-listed regenerative medicine company commercializing skin substitutes and active wound care biologics (Apligraf, Dermagraft, PuraPly). Closest publicly traded analog to Vomaris in selling clinically differentiated, premium-priced advanced wound therapies to the same wound care clinicians.
  • MiMedx: Regenerative wound care and surgical recovery company selling dehydrated amniotic tissue allografts (EpiFix, AmnioFix). Competes for the same surgical wound care and chronic wound care prescribers and shares Vomaris's premium-pricing, evidence-led go-to-market.
  • Integra LifeSciences: Specialty medical device company with a dedicated Wound Care and Surgical Reconstruction franchise (Integra dermal regeneration templates, PriMatrix, AmnioExcel). Sells into the same burn, reconstructive and surgical wound care channels Vomaris targets.

Others

  • Cardinal Health: Major medical products distributor and manufacturer with wound care products (e.g., Kendall AMD antimicrobial dressings, Cardinal Health-brand dressings). Comparable primarily as a distribution and dressing competitor in US hospitals and home health.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Vomaris Innovations social profiles

Digital presence

Vomaris Innovations compliance and trust

Trust signal

Compliance1 record

Vomaris Innovations financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Vomaris Innovations leadership team

Management profile

Number of profiles

Profiles5 records

Vomaris Innovations funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Vomaris Innovations M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vomaris Innovations

What does Vomaris Innovations do?

Vomaris Innovations develops and commercializes bioelectric wound care products powered by its proprietary V.Dox Technology. The platform uses moisture-activated microcell batteries (elemental silver and zinc) that generate wireless microcurrents via a REDOX reaction to mimic the skin's natural transepithelial potential, providing antimicrobial protection and supporting wound healing. The company sells prescription Procellera dressings to healthcare providers, OTC PowerHeal bandages to consumers, and JumpStart dressings to orthopedic surgeons through Arthrex.

Is Vomaris Innovations a public or private company?

Vomaris Innovations is a private company. It is classified as corporate owned and is currently operating.

When was Vomaris Innovations founded?

Vomaris Innovations was founded in 2004. It employs 1 to 10 people.

Where is Vomaris Innovations based?

Vomaris Innovations is headquartered in Tempe, United States, in the North America region.

How does Vomaris Innovations make money?

Four revenue lines are on record. Prescription Wound Care Products are the primary driver. The others are OTC Consumer Products, orthopedic/Sports Medicine Products and licensing Royalties.

Who are Vomaris Innovations's main competitors?

Broad incumbents on record are Smith+Nephew, 3M Health Care (Solventum), Convatec, Mölnlycke Health Care, Coloplast and B. Braun. Direct peers are Organogenesis, MiMedx and Integra LifeSciences. Cardinal Health is listed as an others.

Does Vomaris Innovations have an API?

No public API is recorded for Vomaris Innovations.

What industry is Vomaris Innovations in?

Vomaris Innovations's product category is Advanced Wound Care Devices. Its primary akta.pro industry code is HLAHALAC, Antimicrobial Wound Care (Silver/Iodine/PHMB Dressings, Wound Irrigation), with a secondary code of HLAHALAA, Advanced Wound Dressings (Foam, Hydrocolloid, Alginate, Hydrogel, Film). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswirePowerHeal™ Revolutionizes Wound Care with Introduction of World's First and Only Bioelectric Bandage for Over-The-Counter UseVomaris Innovations, Inc. has launched PowerHeal™, the first FDA-cleared bioelectric bandage available for over-the-counter use in the United States. The product utilizes patented microcell battery technology to accelerate wound healing by up to three times and provides antibacterial protection without antibiotics. This release expands access to advanced medical-grade wound care for consumers treating acute injuries and chronic conditions such as diabetes-related ulcers.PR NewswireTechnology Effective Against Antibiotic-Resistant PathogenVomaris Innovations announced the publication of research demonstrating that its bioelectric V.Dox™ Technology is effective in killing antibiotic-resistant Candida albicans pathogens, with findings published in the journal Bioelectrochemistry. The study, led by researchers at Indiana University's Center for Regenerative Medicine and Engineering, found that the wireless electroceutical wound care dressing worked through multiple mechanisms including preventing hyphal growth, impairing pathogen efflux pumps, damaging cell walls, and disrupting biofilm formation—whereas silver alone was ineffective. The technology is already FDA cleared and represents a novel non-pharmacological approach to addressing the growing problem of antibiotic resistance, which causes over 2.8 million infections annually in the United States alone.PR NewswireVomaris Innovation's Bioelectric Procellera® FlexEFit™ Antibacterial Wound Dressing Receives 2021 Product Innovation Award by LucintelLucintel awarded Vomaris Innovation the 2021 Product Innovation Award for its Procellera® FlexEFit™ Antibacterial Wound Dressing, recognizing the company's V.Dox Technology that uses embedded moisture-activated microcell batteries to generate electricity within the physiological range of wounded skin to drive healing. The technology demonstrates broad-spectrum antimicrobial impact and ability to disrupt and prevent biofilm infection without the use of high-volume ionic silver or added chemicals. The dressing incorporates a patented "link and build" design that enables universal fit over surgical incisions with a single product configuration, addressing a problem impacting over 1.5 million people annually in the US alone.Arizona Daily StarVomaris Seeking Expedited FDA Approval for New Virus-Killing Face MaskVomaris Innovations is seeking FDA Emergency Use Authorization for its V.Dox face masks, which use bioelectric technology to kill viruses. The company's CEO said it is in discussions with mask manufacturers to integrate the technology. A surgeon cited a 0.02% infection rate with the company's dressings.Ortho Spine NewsVomaris Announces Launch of New Microcurrent-Generating Wound Care ProductVomaris Innovations launched Procellera FlexEFit, a microcurrent-generating wound dressing, in the U.S. on March 12, 2019. The product uses V.Dox technology to kill microbes and reduce surgical site infections, which cost up to $10 billion annually in the U.S. The company is expanding distribution globally.PR NewswireBreakthrough Evidence on Vomaris Bioelectric Technology's Impact on Wound Biofilm InfectionVomaris Innovations announced breakthrough preclinical study results published in the Annals of Surgery demonstrating their bioelectric wound dressing technology can prevent and disrupt biofilm infections while restoring functional wound healing. The in vivo porcine model study showed the wireless electroceutical dressing effectively circumvented biofilm formation and restored skin barrier function against mixed-species bacterial infections. The company stated the technology could disrupt the advanced wound care market as a non-antibiotic solution to the growing antimicrobial resistance problem.PR NewswireVomaris' Technology Impacts Biofilm-induced Antibiotic ResistanceVomaris Innovations presented clinical data at the SAWC/WHS Spring conference demonstrating that its Advanced Microcurrent Technology disrupts biofilm-induced antibiotic resistance, with research conducted by Dr. Amitava Das and Professor Chandan Sen's team at Ohio State University using a porcine pre-clinical wound model. The wireless electroceutical device (WED) showed it can present a non-pharmacologic alternative for antimicrobial and antibiofilm efficacy in wound care. The findings address a growing global health threat, with WHO reporting antibiotic resistance currently causes 700,000 deaths annually, projected to rise to 10 million by 2050.PR NewswireVomaris' JumpStart™ Product Recognized with Sports Medicine New Technology AwardVomaris Innovations, Inc. received the 2016 Sports Medicine Technology Award for its JumpStart™ Advanced Microcurrent Technology platform at the American Orthopaedic Society for Sports Medicine annual meeting. The award recognizes the technology's efficacy in wound healing and antimicrobial protection against drug-resistant bacteria. Arthrex, Inc., serves as the exclusive distributor of the product in the US Sports Medicine and Orthopedic Surgery markets.PR NewswireNew In-vivo Study Shows Vomaris' Electroceutical Wound Dressing Disrupts Biofilm on Wound SurfacesVomaris Innovations, Inc. presented findings from an in-vivo study demonstrating that its Advanced Microcurrent Technology® disrupts bacterial biofilms and improves wound healing in a porcine model. The research, led by Professor Chandan Sen at OSU Wexner Medical Center, showed significant decreases in biofilm burden and improvements in re-epithelialization compared to placebo treatments. These results substantiate the antimicrobial efficacy of the company's electroceutical wound dressing technology.